GPS-Guided prostate cancer treatment could cut sessions to just 3
NCT ID NCT06117059
First seen Jan 12, 2026 · Last updated May 08, 2026 · Updated 22 times
Summary
This study tests whether giving only 3 doses of high-precision radiotherapy (SBRT) is as safe and effective as the usual 5 doses for men with early-stage prostate cancer. A special GPS-like system tracks the prostate during treatment to protect nearby organs. About 100 men with low or intermediate risk prostate cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NHS Lothian
RECRUITINGEdinburgh, United Kingdom
Contact
Conditions
Explore the condition pages connected to this study.